NCT07142408 2025-08-26
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
The Cooper Health System
Phase 3 Recruiting
Clinical Trials
15 trialsNCT07137819 2025-08-22
EXACT-1
Aresus Pharma GmbH
Phase 3 Recruiting
NCT05387525 2025-02-11
AKtive
Almirall, S.A.
Phase 4 Active not recruiting
NCT04055142 2024-07-10
TreatAIN
Hospital Universitari Vall d'Hebron Research Institute
Phase 3 Completed
NCT04541290 2022-02-09
Tacrolimus as Treatment of Breast Cancer-Related Lymphedema
Odense University Hospital
Phase 1/2 Completed
NCT03380026 2021-11-24
MIDAS
Rochester Skin Lymphoma Medical Group, PLLC
Phase 2 Completed
NCT04273997 2021-09-22
Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds
S.L.A. Pharma AG
Phase 2 Unknown
NCT03083470 2019-05-15
Study of SOR007 Ointment for Actinic Keratosis
DFB Soria, LLC
Phase 2 Completed
NCT03143491 2017-10-18
Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
DFB Soria, LLC
Phase 2 Withdrawn
NCT01693159 2017-09-25
SUPPORT
National Center for Tumor Diseases, Heidelberg
Phase NA Unknown
NCT02019355 2016-05-19
AK
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT02587819 2016-04-14
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Biosceptre
Phase 1 Completed
NCT01593995 2014-11-04
EGF Ointment for Erlotinib Skin Lesion
Dong-A University Hospital
Phase 2 Completed
NCT01408056 2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2 Withdrawn
NCT01082302 2010-09-08
Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
MediGene
Phase 4 Completed